Home › Funds › Samsara BioCapital, LLC › NKTX
Samsara BioCapital, LLC position in NKTX
NKARTA INC · Health Care
Samsara BioCapital, LLC reported holding 3,507,666 shares of NKTX (NKARTA INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 0.87% of its reported portfolio and ranking #17 among its reported holdings. Samsara BioCapital, LLC has disclosed NKTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Samsara BioCapital, LLC's NKTX position evolved
Samsara BioCapital, LLC first disclosed a stake in NKTX in Q3 2023 at 2,868,035 shares (US$4.0M). The position peaked in Q1 2024 at 3,768,035 shares, worth US$40.7M. Across 13 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 3,507,666 shares valued at US$9.2M. Notable position changes include a 31% increase in Q1 2024 (shares fell 45% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.87M | $3.99M | New |
| Q4 2023 | 2.87M | $18.93M | Hold |
| Q1 2024 | 3.77M | $40.73M | Add |
| Q2 2024 | 3.77M | $22.27M | Hold |
| Q3 2024 | 3.77M | $17.03M | Hold |
| Q4 2024 | 3.77M | $9.38M | Hold |
| Q1 2025 | 3.77M | $6.93M | Hold |
| Q2 2025 | 3.77M | $6.25M | Hold |
| Q3 2025 | 3.77M | $7.80M | Hold |
| Q4 2025 | 3.51M | $6.49M | Reduce |
| Q1 2026 | 3.51M | $7.40M | Hold |
| Q2 2026 | 3.51M | $9.93M | Hold |
| Q3 2026 | 3.51M | $9.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NKTX and 13F data
NKTX (NKARTA INC) is a Health Care company. 24 other funds we track also report a position in NKTX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$28.3M), NEA Management Company, LLC (US$9.4M), SR ONE CAPITAL MANAGEMENT, LP (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NKTX
- RA CAPITAL MANAGEMENT, L.P. 10.81M sh · $28.31M · Q3 2026
- NEA Management Company, LLC 3.57M sh · $9.35M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 3.33M sh · $8.73M · Q3 2026
- GSK plc 3.15M sh · $8.25M · Q3 2026
- Monaco Asset Management SAM 2.19M sh · $5.73M · Q3 2026
- Peapod Lane Capital LLC 518.41K sh · $1.36M · Q3 2026
More on Samsara BioCapital, LLC
FAQ
How long has Samsara BioCapital, LLC held NKTX?
Samsara BioCapital, LLC has disclosed NKTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Samsara BioCapital, LLC's current position in NKTX?
As of Q3 2026, Samsara BioCapital, LLC holds 3.51M shares of NKTX (NKARTA INC), valued at $9.19M, representing 0.87% of its reported portfolio and ranking #17.
Has Samsara BioCapital, LLC been buying or selling NKTX?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC held unchanged its position in NKTX. The position peaked in Q1 2024 at 3.77M shares.
Which other funds hold NKTX?
Other major institutional holders of NKTX include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.